Max pain is the price where the total value of all open calls and puts would be lowest at expiration, so option buyers as a group would lose the most. Some traders watch it as a level the stock may drift toward near expiration, because option sellers, often market makers, hedge their positions in ways that can pull the price toward heavily traded strikes. It is a theory, not a guarantee.

As of the Nov 4, 2026 close, max pain for Vertex Pharmaceuticals options about one week from expiration was $532.14. The chart above shows the exact max pain for each expiration date.

Vertex Pharmaceuticals closed above its near-term max pain on 12 of the last 20 trading days. On Nov 4, 2026 it closed at $549.12, 3.2% above max pain of $532.14.

Over the last 20 trading days, near-term max pain for Vertex Pharmaceuticals ranged from $492.14 to $535.71. It went from $515.71 on Oct 8, 2026 to $532.14 on Nov 4, 2026. See the VRTX max pain history for a longer view.

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases.